Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment
Mette Ødegaard Nielsen, Egill Rostrup, Sanne Wulff, et al.
JAMA Psychiatry (2016) Vol. 73, Iss. 2, pp. 121-121
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Stephen Kaar, Sridhar Natesan, Robert A. McCutcheon, et al.
Neuropharmacology (2019) Vol. 172, pp. 107704-107704
Closed Access | Times Cited: 283
Candidate biomarkers in psychiatric disorders: state of the field
Anissa Abi‐Dargham, Scott J. Moeller, Farzana Ali, et al.
World Psychiatry (2023) Vol. 22, Iss. 2, pp. 236-262
Open Access | Times Cited: 156
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials
Hui Wu, Spyridon Siafis, Tasnim Hamza, et al.
Schizophrenia Bulletin (2022) Vol. 48, Iss. 3, pp. 643-654
Open Access | Times Cited: 73
Distinct neurochemical influences on fMRI response polarity in the striatum
Domenic H. Cerri, Daniel L. Albaugh, Lindsay R. Walton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Spyridon Siafis, Dimitrios Tzachanis, Myrto Samara, et al.
Current Neuropharmacology (2017) Vol. 16, Iss. 8, pp. 1210-1223
Open Access | Times Cited: 130
Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span
Ingrid Dieset, Ole A. Andreassen, Unn K. Haukvik
Schizophrenia Bulletin (2016) Vol. 42, Iss. 6, pp. 1316-1319
Open Access | Times Cited: 95
Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives
Raghunath Singh, Yashika Bansal, Bikash Medhi, et al.
European Journal of Pharmacology (2018) Vol. 844, pp. 231-240
Closed Access | Times Cited: 69
Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized, placebo‐controlled trial
Pelle L. Ishøy, Filip K. Knop, Brian V. Broberg, et al.
Diabetes Obesity and Metabolism (2016) Vol. 19, Iss. 2, pp. 162-171
Open Access | Times Cited: 69
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics
Simona Cernea, Lorena Dima, Christoph U. Correll, et al.
Drugs (2020) Vol. 80, Iss. 17, pp. 1763-1781
Closed Access | Times Cited: 54
Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
Fangyi Zhao, Ziqian Cheng, Jingjing Piao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Mechanism and treatments of antipsychotic-induced weight gain
Wujie Ye, Jingyu Xing, Zekai Yu, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 6, pp. 423-433
Closed Access | Times Cited: 16
Relationship between Duration of Untreated Psychosis and Intrinsic Corticostriatal Connectivity in Patients with Early Phase Schizophrenia
Deepak K. Sarpal, Delbert G. Robinson, Christina L. Fales, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2214-2221
Open Access | Times Cited: 60
Does activation of midbrain dopamine neurons promote or reduce feeding?
Linde Boekhoudt, Theresia J. M. Roelofs, Johannes W. de Jong, et al.
International Journal of Obesity (2017) Vol. 41, Iss. 7, pp. 1131-1140
Closed Access | Times Cited: 56
Altered Volume and Functional Connectivity of the Habenula in Schizophrenia
Lei Zhang, Hao Wang, Shuxin Luan, et al.
Frontiers in Human Neuroscience (2017) Vol. 11
Open Access | Times Cited: 49
Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies
Goda Tarcijonas, Deepak K. Sarpal
Neurobiology of Disease (2018) Vol. 131, pp. 104209-104209
Open Access | Times Cited: 47
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Wade Marteene, Karl Winckel, Samantha Hollingworth, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 12, pp. 1149-1160
Open Access | Times Cited: 47
Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
Maarten Bak, Marjan Drukker, Shauna Cortenraad, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0244944-e0244944
Open Access | Times Cited: 40
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 24
Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology
Nikolaj Bak, Bjørn H. Ebdrup, Bob Oranje, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 4, pp. e1087-e1087
Open Access | Times Cited: 44
Converging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies
Ayşe Sakallı Kani, Ann K. Shinn, Kathryn E. Lewandowski, et al.
Journal of Psychiatric Research (2016) Vol. 84, pp. 256-276
Open Access | Times Cited: 43
Atopic dermatitis induces anxiety- and depressive-like behaviors with concomitant neuronal adaptations in brain reward circuits in mice
Mijung Yeom, Sora Ahn, Ju‐Young Oh, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 98, pp. 109818-109818
Open Access | Times Cited: 36
Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
Jing Huang, Gangrui Hei, Ye Yang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 35
Predicting antipsychotic-induced weight gain in first episode psychosis – A field-wide systematic review and meta-analysis of non-genetic prognostic factors
Ita Fitzgerald, Laura J. Sahm, Amy Byrne, et al.
European Psychiatry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 12
Unveiling Promising Neuroimaging Biomarkers for Schizophrenia Through Clinical and Genetic Perspectives
Jing Guo, Chang-Yi He, Huimiao Song, et al.
Neuroscience Bulletin (2024) Vol. 40, Iss. 9, pp. 1333-1352
Closed Access | Times Cited: 4
Antipsychotic-Induced Weight Gain: What Have We Learned?
Anne M. Silas, Maurizio Musso, Trygve Dolber
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top